13F HOLDINGS REPORT
BROADWOOD CAPITAL INC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0000919574-23-006249
Total Value
$1.12B
Positions
7
Other Managers
1
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MONSTER BEVERAGE CORP NEW | MNST | 8,501,236 | $450.1M | 40.02% |
| 2 | STAAR SURGICAL CO | STAA | 9,264,427 | $372.2M | 33.10% |
| 3 | AXON ENTERPRISE INC | AXON | 760,062 | $151.2M | 13.45% |
| 4 | ISHARES TR | 464287655 | 566,000 | $100.0M | 8.89% |
| 5 | LINEAGE CELL THERAPEUTICS INC | 53566P109 | 34,935,485 | $41.2M | 3.67% |
| 6 | ONCOCYTE CORP | IMDX | 2,509,066 | $7.8M | 0.70% |
| 7 | AGEX THERAPEUTICS INC | 00848H108 | 2,997,156 | $2.0M | 0.18% |